Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Muroyama

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinomaMotohisa Tada, Fumihiko Kanai, Yasuo Tanaka, et al.
Journal of Gastroenterology and Hepatology|October 22, 2017
Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cellsJun Arai, Kaku Goto, Anthony Stephanou, et al.
Journal of Hepatology|February 14, 2017
miR-425 regulates inflammatory cytokine production in CD4<sup>+</sup> T cells via N-Ras upregulation in primary biliary cholangitisRyo Nakagawa, Ryosuke Muroyama, Chisato Saeki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2019
CD4<sup>+</sup> T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoiresRyo Nakagawa, Ryosuke Muroyama, Chisato Saeki, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virusNarayan Dharel, Naoya Kato, Ryosuke Muroyama, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2021
Changes in therapeutic options for hepatocellular carcinoma in AsiaSadahisa Ogasawara, Keisuke Koroki, Hiroaki Kanzaki, et al.
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinomaVinod Kumar, Naoya Kato, Yuji Urabe, et al.
International Journal of Molecular Sciences|July 27, 2022
The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma CellsHiroaki Kanzaki, Tetsuhiro Chiba, Tatsuya Kaneko, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinomaMotohisa Tada, Fumihiko Kanai, Yasuo Tanaka, et al.
Journal of Gastroenterology and Hepatology|October 22, 2017
Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cellsJun Arai, Kaku Goto, Anthony Stephanou, et al.
Journal of Hepatology|February 14, 2017
miR-425 regulates inflammatory cytokine production in CD4<sup>+</sup> T cells via N-Ras upregulation in primary biliary cholangitisRyo Nakagawa, Ryosuke Muroyama, Chisato Saeki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2019
CD4<sup>+</sup> T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoiresRyo Nakagawa, Ryosuke Muroyama, Chisato Saeki, et al.
Hepatology (Baltimore, Md.)|January 29, 2008
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virusNarayan Dharel, Naoya Kato, Ryosuke Muroyama, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2021
Changes in therapeutic options for hepatocellular carcinoma in AsiaSadahisa Ogasawara, Keisuke Koroki, Hiroaki Kanzaki, et al.
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinomaVinod Kumar, Naoya Kato, Yuji Urabe, et al.
International Journal of Molecular Sciences|July 27, 2022
The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma CellsHiroaki Kanzaki, Tetsuhiro Chiba, Tatsuya Kaneko, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2020
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA sheddingJun Arai, Kaku Goto, Yumi Otoyama, et al.
Pageof 6